about
Cancer-associated thrombotic microangiopathyDrug-induced glomerular disease: direct cellular injury.Antineoplastic agents and thrombotic microangiopathy.A case of progressive hypertension preceding gemcitabine-associated thrombotic microangiopathy complicated by acute kidney injury and stroke.Impact of splenectomy on thrombocytopenia, chemotherapy, and survival in patients with unresectable pancreatic cancer.Thrombotic thrombocytopenic purpura and gemcitabine.Breast Cancer-Associated Thrombotic Microangiopathy.Gemcitabine-related thrombotic microangiopathy: a single-centre retrospective series.Gemcitabine-induced hemolytic uremic syndrome in pancreatic cancer: a case report and review of the literature.Successful Remission of Hemolytic-Uremic Syndrome During the Third-line Weekly Gemcitabine for Metastatic Breast CancerProteasome inhibitor associated thrombotic microangiopathy.Rituximab to treat gemcitabine-induced hemolytic-uremic syndrome (HUS) in pancreatic adenocarcinoma: a case series and literature review.Gemcitabine-associated thrombotic microangiopathy in a patient with lung cancer: A case reportGuidelines on the use of therapeutic apheresis in clinical practice--evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis.Pathogenesis, diagnosis and management of paraneoplastic glomerulonephritisDrug-induced nephropathy: an update.The kidney in oncology.Clinical Features of Liver Cancer with Cerebral HemorrhageLong term survivors with metastatic pancreatic adenocarcinoma treated with gemcitabine: a retrospective analysisRituximab plus gemcitabine and oxaliplatin in patients with refractory/relapsed diffuse large B-cell lymphoma who are not candidates for high-dose therapy. A phase II Lymphoma Study Association trialA forgotten cause of kidney injury in chronic myelomonocytic leukemia.Onco-nephrology: current concepts and future perspectives.Role of eculizumab in a pediatric refractory gemcitabine-induced thrombotic microangiopathy: a case report.Thrombotic microangiopathy associated with gemcitabine: rare but real.ASFA Category IV becomes Category I: Idiopathic thrombotic thrombocytopenic purpura in a patient with presumed gemcitabine-induced thrombotic microangiopathy.Digital ischemic changes after gemcitabine therapy in a patient with metastatic non-small-cell lung cancer.Long-term, adverse genitourinary outcomes among endometrial cancer survivors in a large, population-based cohort study.Guidelines for treatment of renal injury during cancer chemotherapy 2016.
P2860
Q26738984-2B5A1A80-A75C-48FD-95C2-BA52B2C16127Q27692666-C56D2392-9A62-4A10-B617-C2A6379DE732Q30251919-6CA7C7DA-5F61-47A3-B1FF-F4A434406889Q33386544-14929C7F-DDCB-46E5-B6A4-8375EE1BD352Q33388860-2CC7B27D-B047-4EF8-8083-E831061F09A1Q33395859-27B05F5E-393A-48E6-AB38-CA234095D9DAQ33400258-F8D7DF83-8317-471F-8CC5-B64827D71E01Q33410709-728FC9BA-60CE-4E56-B1DE-30C06DD70052Q33413284-D717EE3F-ACA5-43A5-BEAA-AC2FF04DA5D4Q33414410-D2EA6E61-AABC-495A-AADE-D5D54DD7F9A3Q33432949-844AB96C-0C0E-47CB-9FFC-5597138D2EB2Q33434397-C0A4FAF2-0109-4FF5-A88E-36BEB432595AQ33441480-6F02DF95-728D-4BBC-B7F3-8D641B9B5F8CQ34122035-6248CC6C-F30D-4B5F-9FC9-B6A87C31AA18Q34684475-25FCB36F-20F2-4F9B-BAE1-C9C923ADDA02Q36191026-2121BFF3-3E10-4814-9F25-19CF356541E0Q36900332-95C964F7-C957-41FA-9065-2FBB3E61FB18Q37032225-43CD274F-3D06-411F-9DA8-80B7B88E52EBQ37145924-64DCF40D-CF1D-4C37-9792-832B4FB4E825Q37273186-87646E73-B742-4CC1-8032-40C4110628DFQ37299461-3E9274DE-FDE2-4519-B42E-BA8704E394D1Q38382457-DC798A56-9FFD-477E-84CE-7B7B135ECF58Q41146886-1067406A-96C7-4D29-9786-F466514A893FQ45978337-B86DAA01-804C-4D15-9484-258375D0F410Q47630342-E183AF49-06E8-4A6D-9C38-50ED83E1C59DQ48582474-8FF1A09F-C297-4925-9289-1DB7641A03B6Q49387212-EA30DAA2-84B5-41C6-B015-8A7ADA41F61CQ50063006-54D9D94B-0D9E-4C70-A9C5-AEF212FEAE7A
P2860
description
2004 nî lūn-bûn
@nan
2004 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Gemcitabine-associated thrombotic microangiopathy.
@ast
Gemcitabine-associated thrombotic microangiopathy.
@en
type
label
Gemcitabine-associated thrombotic microangiopathy.
@ast
Gemcitabine-associated thrombotic microangiopathy.
@en
prefLabel
Gemcitabine-associated thrombotic microangiopathy.
@ast
Gemcitabine-associated thrombotic microangiopathy.
@en
P2093
P356
P1433
P1476
Gemcitabine-associated thrombotic microangiopathy.
@en
P2093
Andrew X Zhu
Benjamin D Humphreys
Colm C Magee
Helmut G Rennke
Jeff P Sharman
Jeffrey W Clark
Peter W Marks
P304
P356
10.1002/CNCR.20290
P407
P577
2004-06-01T00:00:00Z